News

Peptide research news

Recent reporting from peer-reviewed journals, clinical trial readouts, and reputable outlets. Curated by Perplexity, sources cited.

geroscience
PubMed·today

Dietary geroprotective peptides: structural determinants, AI-driven design, and longevity pathways

Review of dietary geroprotective peptides and the structural features that drive bioactivity, with emphasis on AI-assisted design and longevity pathways such as Nrf2, IIS, and mTOR.

Read on pubmed.ncbi.nlm.nih.gov
regulation
Peptide Science Daily·4 days ago

Peptide Research News

Reported that FDA reviewers found little human evidence for BPC-157, TB-500, and five other peptides ahead of the July 23-24 advisory committee meeting.

Read on peptidesciencedaily.com
safety
Reuters·7 days ago

Study flags need to monitor frailty risks with GLP-1 drugs in older adults

A large study raised concerns about possible frailty risks in older adults taking GLP-1 obesity drugs, including Zepbound, as Medicare access to GLP-1 therapies expanded for eligible beneficiaries.

Read on reuters.com
regulatory
Reuters·7 days ago

Novo Nordisk wins EU approval for Wegovy weight-loss pill

Novo Nordisk won EU approval for oral Wegovy, covering adults with obesity or overweight plus a weight-related condition alongside diet and exercise.

Read on reuters.com
conference
Clinical Nutrition Center·7 days ago

Retatrutide Breaks 30%: ADA 2026 Obesity Pipeline

A conference recap highlighted retatrutide obesity and diabetes data, including extension findings and competitor readouts such as survodutide.

Read on clinicalnutritioncenter.com
research index / trials
Peptide Benchmark·7 days ago

Peptides

A peptide-tracking index updated July 15 that aggregates PubMed and trial activity across multiple peptide candidates. It includes recent status changes and trial counts for agents such as eloralintide, apelin, and oxytocin, but is not a primary news source.

Read on peptidebenchmark.com
oncology
PubMed·7 days ago

STK25 Inhibits Epithelial-Mesenchymal Transition and Metastasis via the TGF-β/SMAD2 Signaling Pathway in Colorectal Cancer

Identifies STK25 as a regulator of epithelial-mesenchymal transition and metastasis in colorectal cancer through TGF-β/SMAD2 signaling. The snippet does not indicate a peptide therapeutic, so it is a weaker peptide-news fit.

Read on pubmed.ncbi.nlm.nih.gov
peptide discovery
PubMed·8 days ago

Genetically Encoding Propiolamide Warhead for the Construction of Phage Displayed Cyclic Peptide Library

Researchers reported a genetically encoded propiolamide warhead for building phage-displayed cyclic peptide libraries, and used biopanning to identify a cyclic peptide inhibitor targeting SARS-CoV-2 main protease.

Read on pubmed.ncbi.nlm.nih.gov
regulation
Peptide Evolution·8 days ago

FDA Advisory Committee to Weigh BPC-157, TB-500, MOTS-c ...

Previewed the FDA advisory committee's July 2026 review of BPC-157, TB-500, and MOTS-c, including the indications under discussion.

Read on pepevolution.com